Candidate | Indication | Discovery | Pre-clinical | Phase 1 / IIT | Phase 2/3 |
---|---|---|---|---|---|
FRα CoStAR IIT (Publications) |
NSCLC |
NSCLC: non-small cell lung cancer; FRα: Folate Receptor α
Candidate | Indication | Discovery | Pre-clinical | Phase 1 / IIT | Phase 2/3 |
---|---|---|---|---|---|
FRα CoStAR IIT (Publications) |
NSCLC |
NSCLC: non-small cell lung cancer; FRα: Folate Receptor α